Recurrent bacterial vaginosis

Current Opinion in Infectious Diseases

Volumn 22, Issue 1, 2009, Pages 82-86

  Hay, Phillip ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Antibiotic therapy; Bacterial vaginosis; Pathogenesis; Probiotics; Recurrence

Indexed keywords

ACETIC ACID; AZITHROMYCIN; CLINDAMYCIN; LACTIC ACID; METRONIDAZOLE; NYSTATIN; PLACEBO; PROBIOTIC AGENT;

ACIDIFICATION; ANTIBIOTIC THERAPY; BIOFILM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSAGE FORM; DRUG WITHDRAWAL; FOLLOW UP; GARDNERELLA VAGINALIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTOBACILLUS GASSERI; LACTOBACILLUS RHAMNOSUS; MENSTRUATION; PATHOGENESIS; PREGNANCY OUTCOME; RECURRENT INFECTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; VAGINITIS;

ACTINOBACTERIA; BIOFILMS; CHEMOPREVENTION; FEMALE; GARDNERELLA; HUMANS; METRONIDAZOLE; RECURRENCE; VAGINOSIS, BACTERIAL;

EID: 58849121451     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32832180c6     Document Type: Review

References (32)

1. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353:1899-1911.
2. Verhelst R, Verstraelen H, Claeys G, et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 2004; 4:16.
3. Fredricks DN, Fiedler TL, Thomas KK, et al. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 2007; 45:3270-3276.
4. Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005; 106:1013-1023.
5. Swidsinski A, Mendling W, Loening-Baucke V, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 2008; 198:97-106. The description of persistent biofilm after treatment should lead to a search for better treatments and maybe a way of reducing relapse.
6. Saunders S, Booking A, Challis J, Reid G. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf B Biointerfaces 2007; 55:138-142.
7. Patterson JL, Girerd PH, Karjane NW, Jefferson KK. Effect of biofilm pheno-type on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol 2007; 197:170-177.
8. Ness RB, Kip KE, Soper DE, et al. Variability of bacterial vaginosis over 6- to 12-month intervals. Sex Transm Dis 2006; 33:381 -385.
9. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193:1478-1486.
10. Bradshaw CS, Tabrizi SN, Fairley CK, et al. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 2006; 194:828-836.
11. Hay P. Life in the littoral zone: lactobacilli losing the plot. Sex Transm Infect 2005; 81:100-102.
12. Wilson JD, Lee RA, Balen AH, Rutherford AJ. Bacterial vaginal flora in relation to changing oestrogen levels. Int J STD AIDS 2007; 18:308-311.
13. Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001; 185:1209-1217.
14. Anon. CDC Sexually Transmitted Disease Treatment Guidelines 2006. MMWR 2006; 55:50-52.
15. Clinical Effectiveness Group British Association for Sexual Health and HIV. National Guideline for the Management of Bacterial Vaginosis (2006). http://www.bashh.org/documents/62/62.pdf 2006.
16. Alfonsi GA, Shlay JC, Parker S, Neher JO. What is the best approach for managing recurrent bacterial vaginosis? J Fam Pract 2004; 53:650-652.
17. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194:1283-1289.
18. Sanchez S, Garcia PJ, Thomas KK, et al. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. Am J Obstet Gynecol 2004; 191:1898-1906.
19. Schwebke JR, Desmond R. A randomized trial of metronidazole in asympto-matic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol 2007; 196'.517-526. A provocative study which will need replication before changing guidelines on treating asymptomatic bacterial vaginosis.
20. Gibbs RS. Asymptomatic bacterial vaginosis: is it time to treat? Am J Obstet Gynecol 2007; 196:495-496.
21. Schwebke JR, Desmond RA. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 2007; 44:213-219. An important though mostly negative study showing that antibiotic therapy more aggressive than standard metronidazole does not provide better long-term cure of bacterial vaginosis.
22. Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther 2008; 30:453-468.
23. Anukam KC, Osazuwa C, Osemene Gl, et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006; 8:2772-2776.
24. Shalev E, Battino S, Weiner E, et al. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996; 5:593-596.
25. Neri A, Sabah G, Samra Z. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstet Gynecol Scand 1993; 72:17-19.
26. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008; 8:3. doi:10.1186/1472-6874-8-3.
27. Holley RL, Richter HE, Varner RE, et al. A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis. Sex Transm Dis 2004; 31:236-238.
28. Boeke AJ, Dekker JH, van Eijk JT, et al. Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial. Genitourin Med 1993; 69:388-392.
29. Andersch B, Forssman L, Lincoln K, Torstensson P. Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole. Gynecol Obstet Invest 1986; 21:19-25.
30. Decena DC, Co JT, Manalastas RM Jr, et al. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol Res 2006; 32:243-251.
31. Wilson JD, Shann SM, Brady SK, et al. Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment. Int J STD AIDS 2005; 16:736-738.
32. Rousseau V, Lepargneur JP, Roques C, et al. Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms. Anaerobe 2005; 11:145-153.